FAST4TMA: A national rapid ADAMTS13 testing initiative for TMA patients — 2025 update

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Clinical laboratory diagnostics and monitoring of ADAMTS13 deficiency and of related diseases: an integrated approach2026
2. 2Optimizing ADAMTS13 prophylaxis to reduce relapse and organ failure in congenital thrombotic thrombocytopenic purpura2025
3. 3PO23 | Plasmic score applicability for the diagnosis of thrombotic microangiopathy associated with acquired ADAMTS13 deficiency in emergency settings at the hub laboratory of AUSL Romagna: state of the art and future prospects2025
4. 4ADAMTS13 Deficiency in the Immune and Hereditary Forms of Thrombotic Thrombocytopenic Purpura2025 · 1 citations
5. 5Recombinant ADAMTS13 prophylaxis in patients with congenital thrombotic thrombocytopenic purpura: Final analysis from A phase 3 randomized, controlled study2025